ESG

A new report reveals a major gap in AI adoption as digital disruptors and generic GLP-1s force Canadian pharmacies to innovate or risk being left behind.

As Canyon Resources starts trial mining in Cameroon, targeting Q2 2026 production, a major executive shuffle introduces new risks and opportunities.

Recent deals by CTP reflect soaring demand in Poland, as a resilient economy and shifting supply chains cement its status as a European logistics powerhouse.

AIxCrypto is advancing on three fronts—tokenized assets, AI agents, and robotics—to build an autonomous economy. Here’s a look at their ambitious plan.

Nutraville's new brain supplement CogniSurge touts a 'glycocalyx' fix. We examine the science, the sales pitch, and what consumers should know.

The Vermont ski maker's new certification signals a shift from carbon neutrality to verified climate action. Can performance and planet truly coexist?

Orla Mining reports robust Q1 output and secures a key permit in Mexico, keeping it on track for its 2026 guidance and fueling its growth pipeline.

How one California school district modernized its campuses and trained students for green jobs—all without burdening taxpayers. Here's the financial blueprint.

A landmark grant funds research into scaffold-free tissue, a revolutionary approach that could one day eliminate the need for many knee replacements.

A global partnership aims to bring Atla-cel, a next-gen CAR-T therapy with low neurotoxicity, to children with leukaemia, potentially revolutionizing treatment.

As the $525B cold chain market booms and regulations tighten, Circle Logistics is enhancing its services to offer shippers greater reliability and compliance.

Riyadh's upcoming wood exhibition is more than a trade fair; it's a strategic pillar for Saudi Arabia's multi-trillion-dollar industrial transformation.

Vitruvius Built's founder is named to the LUXE NEXT list, joining just three other builders nationwide and shining a spotlight on Park City's luxury market.

A new once-daily pill for hypoparathyroidism begins human testing, promising to replace burdensome injections and transform patient care. Is this the future?

A novel drug combination shows promising early results for a deadly ovarian cancer, potentially expanding the benefit of immunotherapy to more patients.

A new Salt Lake City center offers a perpetual open house, with full-scale temple room replicas designed to demystify Latter-day Saint worship for all.

A landmark treaty faces opposition from neighboring First Nations, who claim it infringes on their territory and undermines reconciliation on BC's North Coast.

CHEMEON Surface Technology streamlines its executive team to a C-level structure, aiming to accelerate innovation in hexavalent chrome alternatives.

With new funding, ImageneBio advances its unique OX40 inhibitor, IMG-007, for eczema and alopecia, but faces a divided Wall Street.

With youth melanoma a growing concern, a new curriculum gives teens free, classroom-ready tools to build lifelong sun safety habits and reduce their risk.